Abgenix Appoints Donald R. Joseph as Senior Vice President, General Counsel and Secretary
Abgenix, Inc. announced the appointment of Donald R. Joseph as Senior Vice President, General Counsel and Secretary. Mr. Joseph's appointment follows the departure of Susan L. Thorner, who resigned earlier this year to pursue other opportunities.
Before joining Abgenix, Mr. Joseph was the co-founder of Alekta Group, LLC, a specialty pharmaceutical consulting group and pharmaceutical development company. Prior to Alekta he was the Executive Vice President, Commercial Development of Amarin Corp. and the Executive Vice President, Legal and Commercial Development for Amarin Pharmaceuticals, its U.S. subsidiary, for three years. He was responsible for U.S. in-licensing and product acquisition transactions, commercial transition for acquired products, U.S. legal affairs, human resources and administration. From 1998 until 2001, Mr. Joseph worked at Elan Pharmaceuticals, most recently as Senior Vice President for commercial and legal affairs. Following Elan's acquisition of Athena Neurosciences, Inc. in 1996, he served as Vice President and General Counsel for Athena. From 1978 until 1993, Mr. Joseph practiced law with law firms in Oklahoma, San Francisco and San Diego. Before joining Athena Neurosciences in 1994, he was a partner in the San Francisco office of Baker & McKenzie, a prominent international law firm.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
